The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global H1 Receptor Antagonist Market Research Report 2024

Global H1 Receptor Antagonist Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1766287

No of Pages : 100

Ask Your Query

Synopsis
H1 receptor antagonists (H1 receptor antagonists, referred to as H1RAS) prevent histamine from acting on target cells by reversibly competing for histamine receptor sites on cells, and play a role by blocking and antagonizing H1 receptors. Anti-allergic effect, in order to prevent a series of physiological reactions from happening.

Global H1 Receptor Antagonist market is projected to reach US$ 58370 million in 2029, increasing from US$ 34700 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole H1 Receptor Antagonist market research.

Key manufacturers engaged in the H1 Receptor Antagonist industry include Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck and Johnson and Johnson, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of H1 Receptor Antagonist were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole H1 Receptor Antagonist market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global H1 Receptor Antagonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Teva
  • Bayer
  • Pfizer
  • LETI
  • Novartis
  • Hypera Pharma
  • Woodward
  • Merck
  • Johnson and Johnson
  • Ethical pharma
  • Gems pharma
  • KPL Pharma
  • GlaxoSmithKline
  • Ying Yuan
  • Schering-Plough

Segment by Type

  • First Generation H1RAS
  • Second-generation H1RAS
  • Third-generation H1RAS

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The H1 Receptor Antagonist report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 H1 Receptor Antagonist Market Overview
1.1 Product Overview and Scope of H1 Receptor Antagonist
1.2 H1 Receptor Antagonist Segment by Type
1.2.1 Global H1 Receptor Antagonist Market Value Comparison by Type (2023-2029)
1.2.2 First Generation H1RAS
1.2.3 Second-generation H1RAS
1.2.4 Third-generation H1RAS
1.3 H1 Receptor Antagonist Segment by Application
1.3.1 Global H1 Receptor Antagonist Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global H1 Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global H1 Receptor Antagonist Revenue 2018-2029
1.4.2 Global H1 Receptor Antagonist Sales 2018-2029
1.4.3 Global H1 Receptor Antagonist Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 H1 Receptor Antagonist Market Competition by Manufacturers
2.1 Global H1 Receptor Antagonist Sales Market Share by Manufacturers (2018-2023)
2.2 Global H1 Receptor Antagonist Revenue Market Share by Manufacturers (2018-2023)
2.3 Global H1 Receptor Antagonist Average Price by Manufacturers (2018-2023)
2.4 Global H1 Receptor Antagonist Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of H1 Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of H1 Receptor Antagonist, Product Type & Application
2.7 H1 Receptor Antagonist Market Competitive Situation and Trends
2.7.1 H1 Receptor Antagonist Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest H1 Receptor Antagonist Players Market Share by Revenue
2.7.3 Global H1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1 Receptor Antagonist Retrospective Market Scenario by Region
3.1 Global H1 Receptor Antagonist Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global H1 Receptor Antagonist Global H1 Receptor Antagonist Sales by Region: 2018-2029
3.2.1 Global H1 Receptor Antagonist Sales by Region: 2018-2023
3.2.2 Global H1 Receptor Antagonist Sales by Region: 2024-2029
3.3 Global H1 Receptor Antagonist Global H1 Receptor Antagonist Revenue by Region: 2018-2029
3.3.1 Global H1 Receptor Antagonist Revenue by Region: 2018-2023
3.3.2 Global H1 Receptor Antagonist Revenue by Region: 2024-2029
3.4 North America H1 Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America H1 Receptor Antagonist Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America H1 Receptor Antagonist Sales by Country (2018-2029)
3.4.3 North America H1 Receptor Antagonist Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe H1 Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe H1 Receptor Antagonist Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe H1 Receptor Antagonist Sales by Country (2018-2029)
3.5.3 Europe H1 Receptor Antagonist Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H1 Receptor Antagonist Market Facts & Figures by Country
3.6.1 Asia Pacific H1 Receptor Antagonist Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific H1 Receptor Antagonist Sales by Country (2018-2029)
3.6.3 Asia Pacific H1 Receptor Antagonist Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America H1 Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America H1 Receptor Antagonist Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America H1 Receptor Antagonist Sales by Country (2018-2029)
3.7.3 Latin America H1 Receptor Antagonist Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa H1 Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa H1 Receptor Antagonist Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa H1 Receptor Antagonist Sales by Country (2018-2029)
3.8.3 Middle East and Africa H1 Receptor Antagonist Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global H1 Receptor Antagonist Sales by Type (2018-2029)
4.1.1 Global H1 Receptor Antagonist Sales by Type (2018-2023)
4.1.2 Global H1 Receptor Antagonist Sales by Type (2024-2029)
4.1.3 Global H1 Receptor Antagonist Sales Market Share by Type (2018-2029)
4.2 Global H1 Receptor Antagonist Revenue by Type (2018-2029)
4.2.1 Global H1 Receptor Antagonist Revenue by Type (2018-2023)
4.2.2 Global H1 Receptor Antagonist Revenue by Type (2024-2029)
4.2.3 Global H1 Receptor Antagonist Revenue Market Share by Type (2018-2029)
4.3 Global H1 Receptor Antagonist Price by Type (2018-2029)
5 Segment by Application
5.1 Global H1 Receptor Antagonist Sales by Application (2018-2029)
5.1.1 Global H1 Receptor Antagonist Sales by Application (2018-2023)
5.1.2 Global H1 Receptor Antagonist Sales by Application (2024-2029)
5.1.3 Global H1 Receptor Antagonist Sales Market Share by Application (2018-2029)
5.2 Global H1 Receptor Antagonist Revenue by Application (2018-2029)
5.2.1 Global H1 Receptor Antagonist Revenue by Application (2018-2023)
5.2.2 Global H1 Receptor Antagonist Revenue by Application (2024-2029)
5.2.3 Global H1 Receptor Antagonist Revenue Market Share by Application (2018-2029)
5.3 Global H1 Receptor Antagonist Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva H1 Receptor Antagonist Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer H1 Receptor Antagonist Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer H1 Receptor Antagonist Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 LETI
6.4.1 LETI Corporation Information
6.4.2 LETI Description and Business Overview
6.4.3 LETI H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LETI H1 Receptor Antagonist Product Portfolio
6.4.5 LETI Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis H1 Receptor Antagonist Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Hypera Pharma
6.6.1 Hypera Pharma Corporation Information
6.6.2 Hypera Pharma Description and Business Overview
6.6.3 Hypera Pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hypera Pharma H1 Receptor Antagonist Product Portfolio
6.6.5 Hypera Pharma Recent Developments/Updates
6.7 Woodward
6.6.1 Woodward Corporation Information
6.6.2 Woodward Description and Business Overview
6.6.3 Woodward H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Woodward H1 Receptor Antagonist Product Portfolio
6.7.5 Woodward Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merck H1 Receptor Antagonist Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Johnson and Johnson
6.9.1 Johnson and Johnson Corporation Information
6.9.2 Johnson and Johnson Description and Business Overview
6.9.3 Johnson and Johnson H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Johnson and Johnson H1 Receptor Antagonist Product Portfolio
6.9.5 Johnson and Johnson Recent Developments/Updates
6.10 Ethical pharma
6.10.1 Ethical pharma Corporation Information
6.10.2 Ethical pharma Description and Business Overview
6.10.3 Ethical pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ethical pharma H1 Receptor Antagonist Product Portfolio
6.10.5 Ethical pharma Recent Developments/Updates
6.11 Gems pharma
6.11.1 Gems pharma Corporation Information
6.11.2 Gems pharma H1 Receptor Antagonist Description and Business Overview
6.11.3 Gems pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gems pharma H1 Receptor Antagonist Product Portfolio
6.11.5 Gems pharma Recent Developments/Updates
6.12 KPL Pharma
6.12.1 KPL Pharma Corporation Information
6.12.2 KPL Pharma H1 Receptor Antagonist Description and Business Overview
6.12.3 KPL Pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.12.4 KPL Pharma H1 Receptor Antagonist Product Portfolio
6.12.5 KPL Pharma Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Corporation Information
6.13.2 GlaxoSmithKline H1 Receptor Antagonist Description and Business Overview
6.13.3 GlaxoSmithKline H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GlaxoSmithKline H1 Receptor Antagonist Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
6.14 Ying Yuan
6.14.1 Ying Yuan Corporation Information
6.14.2 Ying Yuan H1 Receptor Antagonist Description and Business Overview
6.14.3 Ying Yuan H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Ying Yuan H1 Receptor Antagonist Product Portfolio
6.14.5 Ying Yuan Recent Developments/Updates
6.15 Schering-Plough
6.15.1 Schering-Plough Corporation Information
6.15.2 Schering-Plough H1 Receptor Antagonist Description and Business Overview
6.15.3 Schering-Plough H1 Receptor Antagonist Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Schering-Plough H1 Receptor Antagonist Product Portfolio
6.15.5 Schering-Plough Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H1 Receptor Antagonist Industry Chain Analysis
7.2 H1 Receptor Antagonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H1 Receptor Antagonist Production Mode & Process
7.4 H1 Receptor Antagonist Sales and Marketing
7.4.1 H1 Receptor Antagonist Sales Channels
7.4.2 H1 Receptor Antagonist Distributors
7.5 H1 Receptor Antagonist Customers
8 H1 Receptor Antagonist Market Dynamics
8.1 H1 Receptor Antagonist Industry Trends
8.2 H1 Receptor Antagonist Market Drivers
8.3 H1 Receptor Antagonist Market Challenges
8.4 H1 Receptor Antagonist Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock